Kim Dalziel

Dr. Kim Dalziel

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 September 2016 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
CRCalum T Roberts
Calum T Roberts
LOLouise S Owen
Louise S Owen
BMBrett J Manley
Brett J Manley
DFDag H Frøisland
Dag H Frøisland
SDSusan M Donath
Susan M Donath
HIHIPSTER Trial Investigators
HIPSTER Trial Investigators
Treatment with nasal high-flow therapy has efficacy similar to that of nasal continuous positive airway pressure (CPAP) when used as postextubation support in neonates. The efficacy of high-flow therapy as the primary means of respiratory support for preterm infants with respiratory distress has not been proved.

1 September 2016 in International Journal of Cardiology
Verified
Journal Article
Closed access
CSChris Schilling
Chris Schilling
KDKim Dalziel
Kim Dalziel
RNRussell Nunn
Russell Nunn
KPKarin Du Plessis
Karin Du Plessis
WSWilliam Y. Shi
William Y. Shi
YDYves D'UDekem
Yves D'UDekem

1 September 2006 in American Journal of Rhinology
Verified
Journal Article
Closed access
KDKim Dalziel
Kim Dalziel
KSKen Stein
Ken Stein
ARAli Round
Ali Round
RGRuth Garside
Ruth Garside
PRPam Royle
Pam Royle
Background: Functional endoscopic sinus surgery (FESS) has been used for >20 years for the management of sinus disease including the excision of nasal polyps. Our objective was to perform a systematic review of safety and effectiveness of FESS for the removal of nasal polyps. Methods: The Cochrane Library, MEDLINE, Embase, Science Citation Index, other databases, and websites were searched in January and December 2005 using key words for nasal polyps and endoscopic surgery. All randomized controlled trials, nonrandomized comparative studies, and case series studies that described outcomes associated with FESS for the excision of nasal polyps were included. Forty-two publications were included from the 632 (6.6%) articles initially identified. Two reviewers assessed validity of included studies and extracted relevant data. Results: Three randomized controlled trials, 4 nonrandomized comparative studies, and 35 case series studies were included in the review. FESS was compared with endoscopic polypectomy, Caldwell-Luc, radical nasalization, and intranasal ethmoidectomy. In general, studies were of poor quality and lacked description of important variables influencing surgical outcome. Overall complications for FESS from case series studies ranged from 0.3 to 22.4% (median, 7.0%). Major complications ranged from 0 to 1.5% (median, 0%) and minor complications ranged from 1.1 to 20.8% (median, 7.5%). The potentially most serious complications were cerebrospinal fluid leaks, injury to the internal carotid artery, dural exposure, meningitis, bleeding requiring transfusion, periorbital/orbital fat exposure, and orbital penetration. Symptomatic improvement ranged from 78 to 88% for FESS compared with 43 to 84% for comparative procedures. From case series, symptomatic improvement ranged from 40 to 98% (median, 88%). Conclusion: FESS may offer some advantages in safety and effectiveness over comparative techniques, but wide variation in reported results and methodological shortcomings of studies limit the certainty of these conclusions. Wide variation in complication rates suggests the need for audit of existing practice. Additional high-quality studies with a fuller description of potential confounding factors and effect modifiers will help to define the effectiveness of FESS more clearly.

11 May 2018 in Epilepsia
Verified
Journal Article
Closed access
PDF file
KHKatherine B. Howell
Katherine B. Howell
SEStefanie Eggers
Stefanie Eggers
KDKim Dalziel
Kim Dalziel
JRJessica Riseley
Jessica Riseley
SMSimone Mandelstam
Simone Mandelstam
AHA. Simon Harvey
A. Simon Harvey

24 January 2022 in PharmacoEconomics
Verified
Journal Article
Open access
PDF file
Joseph KwonJoseph Kwon
Joseph Kwon
LFLouise Freijser
Louise Freijser
EHElisabeth Huynh
Elisabeth Huynh
MHMartin Howell
Martin Howell
GCGang Chen
Gang Chen
Stavros PetrouStavros Petrou
Stavros Petrou
Background and Aims Patient-reported outcome measures (PROMs) for children (aged ≤ 18 years) present methodological challenges. PROMs can be categorised by their diverse underlying conceptual bases, including functional, disability and health (FDH) status; quality of life (QoL); and health-related quality of life (HRQoL). Some PROMs are designed to be accompanied by preference weights. PROMs should account for childhood developmental differences by incorporating age-appropriate health/QoL domains, guidance on respondent type(s) and design. This systematic review aims to identify generic multidimensional childhood PROMs and synthesise their characteristics by conceptual basis, target age, measurement considerations, and the preference-based value sets that accompany them. Methods The study protocol was registered in the Prospective Register of Systematic Reviews (CRD42021230833), and reporting followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. We conducted systematic database searches for generic multidimensional childhood PROMs covering the period 2012–2020, which we combined with published PROMs identified by an earlier systematic review that covered the period 1992–2011. A second systematic database search identified preference-based value sets for generic multidimensional PROMs. The PROMs were categorised by conceptual basis (FDH status, QoL and HRQoL) and by target age (namely infants and pre-schoolers aged < 5 years, pre-adolescents aged 5–11, adolescents aged 12–18 and multi-age group coverage). Descriptive statistics assessed how PROM characteristics (domain coverage, respondent type and design) varied by conceptual basis and age categories. Involvement of children in PROM development and testing was assessed to understand content validity. Characteristics of value sets available for the childhood generic multidimensional PROMs were identified and compared. Results We identified 89 PROMs, including 110 versions: 52 FDH, 29 QoL, 12 HRQoL, nine QoL-FDH and eight HRQoL-FDH measures; 20 targeted infants and pre-schoolers, 29 pre-adolescents, 24 adolescents and 37 for multiple age groups. Domain coverage demonstrated development trajectories from observable FDH aspects in infancy through to personal independence and relationships during adolescence. PROMs targeting younger children relied more on informant report, were shorter and had fewer ordinal scale points. One-third of PROMs were developed following qualitative research or surveys with children or parents for concept elicitation. There were 21 preference-based value sets developed by 19 studies of ten generic multidimensional childhood PROMs: seven were based on adolescents’ stated preferences, seven were from adults from the perspective of or on behalf of the child, and seven were from adults adopting an adult’s perspective. Diverse preference elicitation methods were used to elicit values. Practices with respect to anchoring values on the utility scale also varied considerably. The range and distribution of values reflect these differences, resulting in value sets with notably different properties. Conclusion Identification and categorisation of generic multidimensional childhood PROMs and value sets by this review can aid the development, selection and interpretation of appropriate measures for clinical and population research and cost-effectiveness-based decision-making.

1 August 2003 in Health Technology Assessment
Verified
Journal Article
Open access
PDF file
KDKim Dalziel
Kim Dalziel
KSK Stein
K Stein
ARA Round
A Round
RGRuth Garside
Ruth Garside
PRP Royle
P Royle
Health Technology Assessment Volume: 7, Issue: 17, Published in September 2003